Epithod®616 is the POC analyzer for entire stages
of diabetes care to measure both Glycated Albumin and HbA1c

The process of commercial lab testing requires long time and high cost.

Point-Of-Care system provides same-visit results with lab quality and precision.

Epithod® 616 improves diabetes management.


Entire Stages of diabetes care

Beyond HbA1c, Glycated Albumin completes diabetes testing

Glycation of albumin and hemoglobin

Glycated Albumin and HbA1c are index of average glucose over the preceding weeks-to-months. They are the results of glycation when glucose molecules spontaneously react with the amine group of proteins by non-enzymatic reaction. If glucose level remains high then level of Glycated Albumin and HbA1c increases.

The differences of reflecting period for

glycemic control

FPG: Measuring the blood glucose at a single point in time.
Glycated Albumin: Measuring the average blood glucose level over the past 2-4 weeks. It is an intermediate marker for glycemic control because of shorter half-life than HbA1c.
HbA1c: Measuring the average blood glucose level over the past 2-4 months as long-term marker.

Usefulness of Glycated Albumin as indicator

for efficacy of therapy

There was mild decrease in % HbA1c, while % Glycated Albumin decreased markedly after intensive insulin therapy. Glycated Albumin is thought to be more sensitive to short-term fluctuations in glucose level and rapidly confirms treatment efficacy due to half-life. When glycemic control changes shortly by starting or changing of diabetes treatment, Glycated Albumin is a more suitable marker than HbA1c.